Targeted small molecules in polymyalgia rheumatica: the emerging role of JAK inhibitors beyond glucocorticoids and DMARDs. - González-Gay MÁ; Álvarez-Rubio M; de Benito-Vernière A; Belhaj-Gandar M; Roca-Magnet M; Vicente-Rabaneda EF; Castañeda S (Expert opinion on pharmacotherapy, 2026)